Therapeutic options for the management of patients with cardiac syndrome X.
Kaski
J C
JC
Coronary Artery Disease Research Unit, Department of Cardiological Sciences, St George's Hospital Medical School, London, UK.
Valenzuela Garcia
L F
LF
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000628:Aminophylline / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D017566:Microvascular Angina / Q000188:drug therapy*; D020108:Nicorandil / Q000627:therapeutic use; D009566:Nitrates / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000700:Analgesics; D002121:Calcium Channel Blockers; D002316:Cardiotonic Agents; D009566:Nitrates; D014665:Vasodilator Agents; D020108:Nicorandil; D000628:Aminophylline; D007099:Imipramine